Retatrutide is a newly developed medication that acts as a strong GLP-1 receptor agonist. This innovative approach holds significant hope for regulating type 2 diabetes. By imitating the actions of natural GLP-1, https://tayarepg280432.fitnell.com/79960986/retatrudiate-a-novel-glp-1-receptor-agonist-for-diabetes-management